Insider Trading activities of Nektar Therapeutics (NKTR)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Nektar Therapeutics (NKTR) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Nektar Therapeutics since year 2005. Table 2 shows the detailed insider transactions of Nektar Therapeutics since 2005. The reporting company's ticker symbol is NKTR. The reporting company's CIK number is 906709.
The total value of stock buying since 2005 is $1,362,985.
The total value of stock sales since 2005 is $220,646,189.
The total value of stock option exercises since 2005 is $67,033,841.


 1   2   3 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Nektar Therapeutics (NKTR).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-07 0 $0 35,000 $1,210,550 35,000 $272,650
2019-06 0 $0 25,000 $842,750 25,000 $180,250
2019-05 0 $0 129,065 $4,211,764 100,000 $720,998
2019-03 0 $0 0 $0 10,000 $51,400
2019-02 0 $0 139,919 $5,906,978 116,119 $893,310
2019-01 0 $0 63,000 $2,697,660 63,000 $673,470
2018-11 0 $0 41,057 $1,570,428 0 $0
2018-09 0 $0 30,250 $1,825,495 10,000 $51,400
2018-08 0 $0 64,250 $3,874,178 30,000 $427,800
2018-06 5,000 $290,431 150,000 $7,592,419 150,000 $1,583,698
2018-05 0 $0 278,720 $23,372,172 245,000 $2,594,297
2018-04 0 $0 288,881 $27,506,781 318,881 $3,021,764
2018-03 0 $0 260,144 $25,758,178 40,000 $282,270
2018-02 0 $0 28,990 $2,404,428 0 $0
2018-01 0 $0 113,333 $8,078,108 267,083 $3,137,583
2017-12 0 $0 83,333 $4,640,814 83,333 $944,996
2017-11 0 $0 500,684 $14,187,019 544,374 $5,633,924
2017-10 0 $0 311,297 $7,603,650 311,297 $3,429,111
2017-09 0 $0 142,029 $3,172,125 126,629 $1,422,983
2017-08 35,000 $628,250 107,370 $2,071,175 83,334 $945,007
2017-07 0 $0 130,000 $2,731,929 130,000 $1,531,798
2017-06 0 $0 101,700 $1,956,707 165,000 $1,076,549
2017-05 0 $0 28,474 $557,864 5,000 $41,849
2017-04 0 $0 307,000 $6,638,150 300,000 $3,586,397
2017-03 0 $0 317,500 $5,324,123 331,500 $2,517,581
2017-02 0 $0 213,610 $2,740,133 237,500 $1,119,074
2017-01 0 $0 87,500 $1,080,625 87,500 $406,875
2016-12 0 $0 87,500 $1,071,000 87,500 $406,875
2016-11 0 $0 101,924 $1,414,980 87,500 $406,875
2016-10 15,000 $202,500 87,500 $1,492,750 87,500 $406,875
2016-09 0 $0 116,000 $2,105,659 238,500 $692,995
2016-08 0 $0 33,736 $590,900 5,000 $25,750
2016-07 0 $0 105,000 $1,579,500 105,000 $490,750
2016-06 0 $0 5,000 $77,500 5,000 $25,750
2016-05 0 $0 6,192 $84,083 16,126 $0
2016-04 0 $0 15,000 $244,050 15,000 $125,549
2016-03 0 $0 15,000 $176,850 15,000 $99,750
2016-02 0 $0 6,562 $78,214 16,123 $0
2016-01 0 $0 108,334 $1,535,526 108,334 $683,036
2015-12 0 $0 200,002 $3,173,280 200,002 $1,319,412
2015-11 0 $0 270,000 $3,777,492 270,000 $1,813,424
2015-10 0 $0 197,500 $2,183,150 230,000 $1,693,825
2015-09 0 $0 179,998 $2,347,171 194,998 $1,341,036
2015-08 0 $0 411,550 $4,443,341 476,666 $3,675,428
2015-07 0 $0 91,668 $1,079,848 106,668 $771,992
2015-06 0 $0 70,000 $836,900 70,000 $507,800
2015-01 0 $0 15,000 $240,000 15,000 $132,150
2014-12 0 $0 273,556 $4,594,282 273,556 $2,105,190
2014-11 0 $0 866,344 $13,597,796 866,344 $10,495,811
2013-08 0 $0 25,000 $310,250 25,000 $285,250
2013-02 0 $0 0 $0 7,500 $0
2012-12 0 $0 0 $0 7,500 $0
2012-09 5,000 $45,904 12,500 $133,250 12,500 $108,250
2012-07 0 $0 24,001 $204,008 24,001 $146,886
2011-12 0 $0 0 $0 2,500 $0
2011-03 0 $0 4,500 $40,500 74,811 $0
2010-05 0 $0 35,000 $488,110 35,000 $214,200
2009-05 0 $0 596 $3,319 1,639 $0
2009-03 0 $0 0 $0 2,500 $0
2008-11 0 $0 1,364 $5,960 48,356 $0
2007-03 11,000 $124,470 17,700 $216,471 0 $0
2007-01 0 $0 3,592 $52,119 45,000 $601,740
2006-11 1,000 $14,650 0 $0 0 $0
2006-08 1,000 $16,350 0 $0 0 $0
2006-05 1,000 $20,350 1,633 $33,002 0 $0
2006-03 1,000 $20,080 14,781 $292,634 0 $0
2006-01 0 $0 80,000 $1,724,520 101,110 $1,910,208
2005-09 0 $0 40,000 $836,249 0 $0
2005-05 0 $0 1,750 $25,322 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Nektar Therapeutics insiders (NKTR)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-07-10 Labrucherie Gil M (SVP & Chief Financial Officer) Sale 25,000 34.57 864,250
2019-07-10 Labrucherie Gil M (SVP & Chief Financial Officer) Option Ex 25,000 7.21 180,250
2019-07-08 Lingnau Lutz (Director) Sale 10,000 34.63 346,300
2019-07-08 Lingnau Lutz (Director) Option Ex 10,000 9.24 92,400
2019-06-17 Labrucherie Gil M (SVP & Chief Financial Officer) Sale 25,000 33.71 842,750
2019-06-17 Labrucherie Gil M (SVP & Chief Financial Officer) Option Ex 25,000 7.21 180,250
2019-05-23 Robin Howard W (President & CEO) Sale 33,333 32.69 1,089,655
2019-05-23 Robin Howard W (President & CEO) Option Ex 33,333 7.21 240,330
2019-05-22 Robin Howard W (President & CEO) Sale 33,334 33.38 1,112,688
2019-05-22 Robin Howard W (President & CEO) Option Ex 33,334 7.21 240,338
2019-05-21 Robin Howard W (President & CEO) Sale 33,333 32.93 1,097,655
2019-05-21 Robin Howard W (President & CEO) Option Ex 33,333 7.21 240,330
2019-05-16 Doberstein Stephen K (SVP & Chief Scientific Officer) Sale 3,461 31.37 108,571
2019-05-16 Hora Maninder (SVP Pharma Dev & Mfg Ops) Sale 2,449 31.37 76,825
2019-05-16 Thomsen Jillian B. (SVP & Chief Accounting Officer) Sale 1,928 31.37 60,481
2019-05-16 Nicholson John (SVP & Chief Operating Officer) Sale 4,077 31.37 127,895
2019-05-16 Labrucherie Gil M (SVP & Chief Financial Officer) Sale 3,767 31.37 118,170
2019-05-16 Robin Howard W (President & CEO) Sale 13,383 31.37 419,824
2019-03-08 Greer R Scott (Director) Option Ex 10,000 5.14 51,400
2019-02-21 Robin Howard W (President & CEO) Sale 33,333 41.01 1,366,986
2019-02-21 Robin Howard W (President & CEO) Option Ex 33,333 7.21 240,330
2019-02-20 Robin Howard W (President & CEO) Sale 33,334 43.20 1,440,028
2019-02-20 Robin Howard W (President & CEO) Option Ex 33,334 7.21 240,338
2019-02-19 Doberstein Stephen K (SVP & Chief Scientific Officer) Sale 3,310 42.39 140,310
2019-02-19 Hora Maninder (SVP Pharma Dev & Mfg Ops) Sale 2,386 42.39 101,142
2019-02-19 Thomsen Jillian B. (SVP & Chief Accounting Officer) Sale 1,808 42.39 76,641
2019-02-19 Nicholson John (SVP & Chief Operating Officer) Sale 3,822 42.39 162,014
2019-02-19 Labrucherie Gil M (SVP & Chief Financial Officer) Sale 3,592 42.39 152,264
2019-02-19 Robin Howard W (President & CEO) Sale 42,215 42.35 1,788,016
2019-02-19 Robin Howard W (President & CEO) Option Ex 33,333 7.21 240,330
2019-02-04 Thomsen Jillian B. (SVP & Chief Accounting Officer) Sale 16,119 42.16 679,577
2019-02-04 Thomsen Jillian B. (SVP & Chief Accounting Officer) Option Ex 16,119 10.69 172,312
2019-01-28 Nicholson John (SVP & Chief Operating Officer) Sale 63,000 42.82 2,697,660
2019-01-28 Nicholson John (SVP & Chief Operating Officer) Option Ex 63,000 10.69 673,470
2018-11-16 Doberstein Stephen K (SVP & Chief Scientific Officer) Sale 4,524 38.25 173,043
2018-11-16 Hora Maninder (SVP Pharma Dev & Mfg Ops) Sale 4,694 38.25 179,545
2018-11-16 Thomsen Jillian B. (SVP & Chief Accounting Officer) Sale 4,016 38.25 153,612
2018-11-16 Nicholson John (SVP & Chief Operating Officer) Sale 5,982 38.25 228,811
2018-11-16 Labrucherie Gil M (SVP & Chief Financial Officer) Sale 6,515 38.25 249,198
2018-11-16 Robin Howard W (President & CEO) Sale 15,326 38.25 586,219
2018-09-20 Ajer Jeffrey Robert (Director) Sale 6,750 56.76 383,130
2018-09-20 Lingnau Lutz (Director) Sale 9,000 56.98 512,820
2018-09-19 Chess Robert (Director) Sale 4,500 56.81 255,645
2018-09-04 Greer R Scott (Director) Sale 10,000 67.39 673,900
2018-09-04 Greer R Scott (Director) Option Ex 10,000 5.14 51,400
2018-08-21 Winger Dennis L (Director) Sale 15,000 60.30 904,500
2018-08-21 Winger Dennis L (Director) Option Ex 15,000 14.26 213,900
2018-08-17 Winger Dennis L (Director) Sale 15,000 59.62 894,300
2018-08-17 Winger Dennis L (Director) Option Ex 15,000 14.26 213,900
2018-08-14 Winger Dennis L (Director) Sale 17,125 60.15 1,030,068
2018-08-13 Winger Dennis L (Director) Sale 17,125 61.04 1,045,310
2018-06-27 Robin Howard W (President & CEO) Sale 43,333 47.39 2,053,550
2018-06-27 Robin Howard W (President & CEO) Option Ex 43,333 10.69 463,229
2018-06-26 Robin Howard W (President & CEO) Sale 43,333 49.36 2,138,916
2018-06-26 Robin Howard W (President & CEO) Option Ex 43,333 10.69 463,229
2018-06-25 Robin Howard W (President & CEO) Sale 43,334 51.82 2,245,567
2018-06-25 Robin Howard W (President & CEO) Option Ex 43,334 10.69 463,240
2018-06-06 Greer R Scott (Director) Sale 8,600 60.00 516,000
2018-06-06 Greer R Scott (Director) Option Ex 8,600 5.14 44,204
2018-06-06 Whitfield Roy A (Director) Buy 3,400 59.44 202,079
2018-06-05 Chess Robert (Director) Sale 10,000 55.16 551,600
2018-06-05 Chess Robert (Director) Option Ex 10,000 14.26 142,600
2018-06-05 Whitfield Roy A (Director) Buy 1,600 55.22 88,352
2018-06-04 Greer R Scott (Director) Sale 1,400 61.99 86,786
2018-06-04 Greer R Scott (Director) Option Ex 1,400 5.14 7,196
2018-05-16 Doberstein Stephen K (SVP & Chief Scientific Officer) Sale 3,435 83.39 286,444
2018-05-16 Hora Maninder (SVP Pharma Dev & Mfg Ops) Sale 4,060 83.39 338,563
2018-05-16 Thomsen Jillian B. (SVP & Chief Accounting Officer) Sale 3,576 83.39 298,202
2018-05-16 Nicholson John (SVP & Chief Operating Officer) Sale 4,917 83.39 410,028
2018-05-16 Labrucherie Gil M (SVP & Chief Financial Officer) Sale 4,941 83.39 412,029
2018-05-16 Robin Howard W (President & CEO) Sale 12,791 83.39 1,066,641
2018-05-03 Labrucherie Gil M (SVP & Chief Financial Officer) Sale 30,000 82.86 2,485,800
2018-05-03 Labrucherie Gil M (SVP & Chief Financial Officer) Option Ex 30,000 10.69 320,700
2018-05-03 Chess Robert (Director) Sale 25,000 82.80 2,070,000
2018-05-03 Chess Robert (Director) Option Ex 25,000 9.70 242,499
2018-05-03 Robin Howard W (President & CEO) Sale 43,333 82.86 3,590,572
2018-05-03 Robin Howard W (President & CEO) Option Ex 43,333 10.69 463,229
2018-05-02 Labrucherie Gil M (SVP & Chief Financial Officer) Sale 30,000 85.63 2,568,900
2018-05-02 Labrucherie Gil M (SVP & Chief Financial Officer) Option Ex 30,000 10.69 320,700
2018-05-02 Robin Howard W (President & CEO) Sale 43,333 85.63 3,710,604
2018-05-02 Robin Howard W (President & CEO) Option Ex 43,333 10.69 463,229
2018-05-01 Labrucherie Gil M (SVP & Chief Financial Officer) Sale 30,000 83.65 2,509,500
2018-05-01 Labrucherie Gil M (SVP & Chief Financial Officer) Option Ex 30,000 10.69 320,700
2018-05-01 Robin Howard W (President & CEO) Sale 43,334 83.65 3,624,889
2018-05-01 Robin Howard W (President & CEO) Option Ex 43,334 10.69 463,240
2018-04-17 Whitfield Roy A (Director) Option Ex 30,000 14.26 427,800
2018-04-16 Thomsen Jillian B. (SVP & Chief Accounting Officer) Sale 13,881 101.46 1,408,366
2018-04-16 Thomsen Jillian B. (SVP & Chief Accounting Officer) Option Ex 13,881 10.69 148,387
2018-04-10 Hora Maninder (SVP Pharma Dev & Mfg Ops) Sale 502 105.67 53,046
2018-04-10 Hora Maninder (SVP Pharma Dev & Mfg Ops) Option Ex 502 7.21 3,619
2018-04-09 Doberstein Stephen K (SVP & Chief Scientific Officer) Sale 49,500 96.13 4,758,435
2018-04-09 Doberstein Stephen K (SVP & Chief Scientific Officer) Option Ex 49,500 7.21 356,895
2018-04-09 Hora Maninder (SVP Pharma Dev & Mfg Ops) Sale 9,498 105.05 997,764
2018-04-09 Hora Maninder (SVP Pharma Dev & Mfg Ops) Option Ex 9,498 7.21 68,480
2018-04-06 Doberstein Stephen K (SVP & Chief Scientific Officer) Sale 110,500 91.69 10,131,745
2018-04-06 Doberstein Stephen K (SVP & Chief Scientific Officer) Option Ex 110,500 8.37 924,884
2018-04-06 Chess Robert (Director) Sale 25,000 92.14 2,303,625
2018-04-06 Chess Robert (Director) Option Ex 25,000 9.70 242,499
2018-04-06 Greer R Scott (Director) Sale 30,000 92.22 2,766,600
2018-04-06 Greer R Scott (Director) Option Ex 30,000 14.26 427,800
2018-04-05 Hora Maninder (SVP Pharma Dev & Mfg Ops) Sale 20,000 101.75 2,035,000
2018-04-05 Hora Maninder (SVP Pharma Dev & Mfg Ops) Option Ex 20,000 7.21 144,200
2018-04-05 Lingnau Lutz (Director) Sale 30,000 101.74 3,052,200
2018-04-05 Lingnau Lutz (Director) Option Ex 30,000 9.24 277,200
2018-03-07 Nicholson John (SVP & Chief Operating Officer) Sale 100,144 100.45 10,059,464
2018-03-07 Kuebler Christopher A (Director) Sale 37,400 97.41 3,643,134
2018-03-07 Kuebler Christopher A (Director) Option Ex 37,400 7.19 268,906
2018-03-06 Nicholson John (SVP & Chief Operating Officer) Sale 120,000 98.29 11,794,800
2018-03-06 Kuebler Christopher A (Director) Sale 2,600 100.30 260,780
2018-03-06 Kuebler Christopher A (Director) Option Ex 2,600 5.14 13,364
2018-02-16 Doberstein Stephen K (SVP & Chief Scientific Officer) Sale 2,426 82.94 201,212
2018-02-16 Hora Maninder (SVP Pharma Dev & Mfg Ops) Sale 2,875 82.94 238,452
2018-02-16 Thomsen Jillian B. (SVP & Chief Accounting Officer) Sale 2,545 82.94 211,082
2018-02-16 Nicholson John (SVP & Chief Operating Officer) Sale 4,879 82.94 404,664
2018-02-16 Labrucherie Gil M (SVP & Chief Financial Officer) Sale 3,477 82.94 288,382
2018-02-16 Robin Howard W (President & CEO) Sale 12,788 82.94 1,060,636
2018-01-31 Nicholson John (SVP & Chief Operating Officer) Option Ex 120,000 11.34 1,360,800
2018-01-22 Robin Howard W (President & CEO) Sale 83,333 75.82 6,318,308
2018-01-22 Robin Howard W (President & CEO) Option Ex 83,333 11.34 944,996
2018-01-04 Winger Dennis L (Director) Option Ex 33,750 11.97 403,987
2018-01-02 Kuebler Christopher A (Director) Sale 30,000 58.66 1,759,800
2018-01-02 Kuebler Christopher A (Director) Option Ex 30,000 14.26 427,800
2017-12-13 Robin Howard W (President & CEO) Sale 83,333 55.69 4,640,814
2017-12-13 Robin Howard W (President & CEO) Option Ex 83,333 11.34 944,996
2017-11-13 Nicholson John (SVP & Chief Operating Officer) Sale 15,910 37.78 601,079
2017-11-13 Nicholson John (SVP & Chief Operating Officer) Option Ex 25,000 9.24 231,000
2017-11-08 Doberstein Stephen K (SVP & Chief Scientific Officer) Sale 300,000 30.09 9,027,000
2017-11-08 Doberstein Stephen K (SVP & Chief Scientific Officer) Option Ex 300,000 9.53 2,859,000
2017-11-07 Doberstein Stephen K (SVP & Chief Scientific Officer) Sale 75,409 25.78 1,944,044
2017-11-07 Doberstein Stephen K (SVP & Chief Scientific Officer) Option Ex 75,409 9.53 718,647
2017-11-07 Hora Maninder (SVP Pharma Dev & Mfg Ops) Option Ex 34,600 18.10 626,260
2017-11-06 Doberstein Stephen K (SVP & Chief Scientific Officer) Sale 20,914 24.98 522,431
2017-11-06 Doberstein Stephen K (SVP & Chief Scientific Officer) Option Ex 20,914 9.53 199,310
2017-11-06 Hora Maninder (SVP Pharma Dev & Mfg Ops) Sale 5,117 25.07 128,283
2017-11-06 Hora Maninder (SVP Pharma Dev & Mfg Ops) Option Ex 5,117 10.69 54,700
2017-11-01 Robin Howard W (President & CEO) Sale 83,334 23.57 1,964,182
2017-11-01 Robin Howard W (President & CEO) Option Ex 83,334 11.34 945,007
2017-10-09 Robin Howard W (President & CEO) Sale 83,333 24.20 2,016,658
2017-10-09 Robin Howard W (President & CEO) Option Ex 83,333 11.34 944,996
2017-10-05 Doberstein Stephen K (SVP & Chief Scientific Officer) Sale 43,677 24.97 1,090,614
2017-10-05 Doberstein Stephen K (SVP & Chief Scientific Officer) Option Ex 43,677 9.53 416,241
2017-10-05 Hora Maninder (SVP Pharma Dev & Mfg Ops) Sale 7,583 25.00 189,575
2017-10-05 Hora Maninder (SVP Pharma Dev & Mfg Ops) Option Ex 7,583 10.69 81,062
2017-10-02 Labrucherie Gil M (SVP & Chief Financial Officer) Sale 120,000 24.45 2,934,000
2017-10-02 Labrucherie Gil M (SVP & Chief Financial Officer) Option Ex 120,000 11.34 1,360,800
2017-10-02 Gergel Ivan P. (SVP & Chief Medical Officer) Sale 56,704 24.21 1,372,803
2017-10-02 Gergel Ivan P. (SVP & Chief Medical Officer) Option Ex 56,704 11.04 626,012
2017-09-29 Gergel Ivan P. (SVP & Chief Medical Officer) Sale 43,296 24.04 1,040,835
2017-09-29 Gergel Ivan P. (SVP & Chief Medical Officer) Option Ex 43,296 11.04 477,987
2017-09-22 Lingnau Lutz (Director) Sale 5,000 21.97 109,850
 1   2   3 

Insider trading activities including stock purchases, stock sales, and option exercises of NKTR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Nektar Therapeutics (symbol NKTR, CIK number 906709) see the Securities and Exchange Commission (SEC) website.